Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eton Pharmaceuticals (ETON) Assets Average (2019 - 2025)

Historic Assets Average for Eton Pharmaceuticals (ETON) over the last 7 years, with Q3 2025 value amounting to $103.1 million.

  • Eton Pharmaceuticals' Assets Average rose 20472.04% to $103.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $103.1 million, marking a year-over-year increase of 20472.04%. This contributed to the annual value of $53.9 million for FY2024, which is 9000.0% up from last year.
  • According to the latest figures from Q3 2025, Eton Pharmaceuticals' Assets Average is $103.1 million, which was up 20472.04% from $92.9 million recorded in Q2 2025.
  • Eton Pharmaceuticals' Assets Average's 5-year high stood at $103.1 million during Q3 2025, with a 5-year trough of $22.3 million in Q3 2022.
  • Its 5-year average for Assets Average is $39.6 million, with a median of $30.5 million in 2021.
  • In the last 5 years, Eton Pharmaceuticals' Assets Average tumbled by 2430.76% in 2022 and then surged by 20472.04% in 2025.
  • Over the past 5 years, Eton Pharmaceuticals' Assets Average (Quarter) stood at $27.0 million in 2021, then decreased by 13.91% to $23.3 million in 2022, then soared by 35.91% to $31.6 million in 2023, then surged by 76.97% to $56.0 million in 2024, then skyrocketed by 84.15% to $103.1 million in 2025.
  • Its last three reported values are $103.1 million in Q3 2025, $92.9 million for Q2 2025, and $80.1 million during Q1 2025.